From: Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies
Gene | Chromosome | No. SNPs | P value | Cancer |
---|---|---|---|---|
RORA | 15 | 8 | 2.95E-04 | Breast_all cases |
PER1 | 17 | 2 | 3.34E-04 | |
RORB | 9 | 5 | 6.49E-04 | |
ARNTL | 11 | 1 | 0.002 | |
CRY2 | 11 | 1 | 0.002 | |
CLOCK | 4 | 1 | 0.006 | |
CRY1 | 12 | 1 | 0.008 | |
RORC | 1 | 1 | 0.010 | |
ARNTL | 11 | 1 | 2.04E-04 | Prostate_all cases |
RORA | 15 | 6 | 2.32E-04 | |
NPAS2 | 2 | 6 | 0.002 | |
RORB | 9 | 1 | 0.005 | |
NR1D1 | 17 | 1 | 0.005 | |
PER3 | 1 | 1 | 0.009 | |
CLOCK | 4 | 1 | 0.010 | |
RORA | 15 | 27 | 2.00E-06 | Lung_all cases |
RORB | 9 | 11 | 9.39E-05 | |
ARNTL | 11 | 17 | 5.94E-04 | |
NPAS2 | 2 | 5 | 7.89E-04 | |
CSNK1E | 22 | 4 | 7.97E-04 | |
PER3 | 1 | 3 | 0.002 | |
PER2 | 2 | 2 | 0.002 | |
CLOCK | 4 | 3 | 0.003 | |
CRY1 | 12 | 2 | 0.007 | |
CRY2 | 11 | 1 | 0.008 | |
NR1D1 | 17 | 2 | 0.017 | |
ARNTL2 | 12 | 1 | 0.028 | |
NR1D2 | 3 | 1 | 0.046 |